Clinical and preclinical evidence for the neurotrophic effects of mood stabilizers: implications for the pathophysiology and treatment of manic–depressive illness
- 1 October 2000
- journal article
- Published by Elsevier in Biological Psychiatry
- Vol. 48 (8) , 740-754
- https://doi.org/10.1016/s0006-3223(00)00979-3
Abstract
No abstract availableKeywords
This publication has 84 references indexed in Scilit:
- Lithium protects cultured neurons against β‐amyloid‐induced neurodegenerationFEBS Letters, 1999
- The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNSJournal of Neurochemistry, 1999
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death MachineryCell, 1997
- Lithium inhibits Alzheimer's disease‐like tau protein phosphorylation in neuronsFEBS Letters, 1997
- More hippocampal neurons in adult mice living in an enriched environmentNature, 1997
- Differential display PCR reveals increased expression of 2′,3′‐cyclic nucleotide 3′‐phosphodiesterase by lithiumFEBS Letters, 1996
- Intracellular Signaling Pathways Activated by Neuropathic FactorsAnnual Review of Neuroscience, 1996
- Anticonvulsants attenuate amyloid β-peptide neurotoxicity, Ca2+ deregulation, and cytoskeletal pathologyNeurobiology of Aging, 1995
- Lithium Delays the Radiation-induced Apoptotic Process in External Granule Cells of Mouse Cerebellum.Journal of Radiation Research, 1995